THE DISEASES OF CARDIOVASCULAR SYSTEM AND RHEUMATIC DISEASES - PowerPoint PPT Presentation

About This Presentation
Title:

THE DISEASES OF CARDIOVASCULAR SYSTEM AND RHEUMATIC DISEASES

Description:

Thrombogenic Immune Clonal Viral Reaction to damage Lipoprotein Neuro-metabolic – PowerPoint PPT presentation

Number of Views:1
Slides: 130
Provided by: drsdas
Tags:

less

Transcript and Presenter's Notes

Title: THE DISEASES OF CARDIOVASCULAR SYSTEM AND RHEUMATIC DISEASES


1
THE DISEASES OF CARDIOVASCULAR SYSTEM AND
RHEUMATIC DISEASES
Federal State Budgetary Educational Institution
of Higher Education Perm State Medical
University named after academician E.A. Wagner
of Ministry of Healthcare of Russian Federation
DR.SOURAV DAS, PERM STATE MEDICAL UNIVERSITY,
RUSSIA
Perm, 2017
2
CARDIOVASCULAR DISEASES
3
ATHEROSCLEROSIS
4
DEFINITION
  • chronic disease resulting from disruption of
    lipid and protein metabolism, characterized by
    damage to the arteries of the elastic and
    muscular-elastic type in the form of focal
    sedimentation in the inner membrane of lipids and
    proteins and the reactive proliferation of
    connective tissue.

5
ETHIOLOGY
  • Polyethological disease associated with the
    influence of various exogenous and endogenous
    factors
  • - Heredity
  • - Environment
  • - Food

6
RISK FACTORS
  • Age
  • Sex (male up to 70)
  • Heredity
  • Hyperlipidemia (hypercholesterolemia)
  • Arterial hypertension
  • Smoking
  • Diabetes mellitus

7
HYPOTHESES
  • Thrombogenic
  • Immune
  • Clonal
  • Viral
  • Reaction to damage
  • Lipoprotein
  • Neuro-metabolic

8
PATHOGENESIS
  • In most cases, the development of atherosclerosis
    is preceded by atherogenic dyslipoproteinemia -
    modified lipoprotein s- capture by endothelial
    cells - transferr to the subendothelial space.
  • Damage of the endothelium - induction of plasma
    components, including lipoproteins, into the
    inner shell of the vessels.
  • The damaged endothelium expresses adhesive
    molecules - adherence (adhesion) of platelets and
    monocytes.

9
PATHOGENESIS
  • Muscular cells - proliferate, synthesize
    collagen, elastic fibers, protheoglycans - the
    basis of an atherosclerotic plaque.
  • Lipoproteins form complexes with proteoglycans
    capture by macrophages - xantom cells.
  • Subsequent changes in the plaque capillaries,
    necrosis of central departments, sclerosis,
    hyalinosis, calcification.

10
(No Transcript)
11
PATHOLOGY PROCESS
  • The main morphological expression of
    atherosclerosis is a plaque, the essence of which
    well reflects the name of the disease
  • in the center - lipid-protein detritus -
    (athere),
  • around - proliferation of connective tissue -
    sclerosis.
  • Usually, the arteries of the elastic (aorta) and
    the musculo-elastic type (large organ arteries)
    are affected, and small arteries of the muscular
    type are much less involved in the process.

12
(No Transcript)
13
(No Transcript)
14
(No Transcript)
15
ATHEROGENESIS
  • Macro
  • grease stains and striae
  • fibrous plaques
  • complicated lesions, represented by fibrous
    plaques with ulceration, hemorrhages and
    overlapping of thrombotic masses
  • calcification or atherocalcinosis

16
GREASE STAINS AND STRIAE
  • areas of yellow or yellow-gray color (spots),
    which sometimes merge and form strips, but do not
    rise above the surface of the inner shell of the
    vessel.
  • They contain lipids, revealed by the total
    coloration of the vessel with dyes for fat, for
    example Sudan.
  • Earlier fat spots and streaks appear in the aorta
    on the back wall and at the point of divergence
    of its branches, later in the large arteries.

17
FIBROUS PLAQUES
  • dense oval or rounded, white or yellow-white
    formations, containing lipids and towering above
    the surface of the inner shell of the vessel.
  • They often merge together, give the inner surface
    a tuberous appearance and lead to a narrowing of
    the lumen of the vessel (stenotic
    atherosclerosis).
  • The most common plaques are located in the
    abdominal aorta, in the arteries of the heart,
    brain, kidneys, lower extremities, carotid
    arteries, etc.
  • Most often affected are those areas of the
    vessels that experience hemodynamic (mechanical)
    effects - in the branching and bending of the
    arteries, on their side wall, which has a rigid
    bedding.

18
COMPLICATED LESIONS
  • Progression of atheromatous changes leads to the
    destruction of plaque carcinomas, ulcerations
    (atheromatous ulcer), hemorrhages in the
    thickness of the plaque (intramural hematoma) and
    the formation of thrombotic overlays at the site
    of ulceration of the plaque.
  • Acute clotting of artery and the development of
    an infarction, embolism with both thrombotic and
    atheromatous masses, the formation of an aneurysm
    of the vessel at the site of its ulceration, as
    well as arterial bleeding when the atheromatous
    ulcer is corroded.

19
ATHEROCALCINOSIS
  • the final phase of atherosclerosis, which is
    characterized by the deposition of calcium salts
    in fibrous plaques, i.e. their calcification.
  • Plaques acquire a stony density (petrification of
    plaques), the wall of the vessel at the place of
    petrification is sharply deformed.

20
IMPORTANT
  • Different types of atherosclerotic changes are
    often combined in the same vessel, for example,
    in the aorta, one can see simultaneously fatty
    spots and bands, fibrous plaques, atheromatous
    ulcers with thrombi and atherocatalcinosis, which
    indicates a wavy course of atherosclerosis.

21
ATHEROGENESIS
  • Micro
  • before lipidosis
  • lipoidosis
  • liposclerosis
  • atheromatosis
  • ulceration
  • atherocalcinosis

22
BEFORE LIPIDOSIS
  • increased permeability and damage to the inner
    shell of the vessel. Lipid droplets appear in
    endothelial cells, sometimes occupying up to 50
    of the cytoplasm.
  • Characterized by edema of endothelial cells, the
    disappearance of glycocalyx, damage to the
    cytomelemma, the disclosure of interendothelial
    contacts, the appearance in the subendothelial
    layer of droplets of fat, plasma proteins,
    fibrinogen (fibrin).

23
LIPOIDOSIS
  • focal infiltration of the inner shell of the
    vessel, especially its surface areas, lipids
    (cholesterol), lipoproteins, proteins, which
    leads to the formation of fat spots and bands.
  • Lipids diffusely impregnate the inner membrane
    and accumulate in the muscular cells and
    macrophages, which turn into xantom cells.
    Expressed swelling and destruction of elastic
    membranes.

24
LIPOSCLEROSIS
  • proliferation of connective tissue elements of
    the inner shell of vessels in the areas of
    deposition and decomposition of lipids and
    proteins, what leads to the formation of fibrous
    plaque.
  • At the edges of the plaque, a new formation of
    thin-walled vessels takes place, which also
    become an additional source of lipoprotein and
    plasma protein intake.

25
ATHEROMATOSIS
  • the lipid masses that make up the central part of
    the plaque, as well as the adjacent collagen and
    elastic fibers, decay. At the same time, an
    amorphous mass is formed in which cholesterol
    crystals are detected (atheromatous detritus).
  • Atheromatous masses are delimited from the lumen
    of the vessel by a layer of mature, sometimes
    hyalineized connective tissue (plaque cover).
  • The muscular membrane often atrophies, sometimes
    undergoes atheromatous decay, as a result of
    which the plaque reaches in some cases the outer
    shell of the vessels.

26
ULCERATION
  • With the progression of atheromatosis, in
    connection with the destruction of newly formed
    vessels, a hemorrhage into the thickness of the
    plaque (intramural genome) occurs.
  • In case of destruction of the plaque cover, an
    atheromatous ulcer is formed.
  • The defect of the inner shell of the vessel is
    often covered by thrombotic masses.

27
ATHEROCALCINOSIS
  • the final stage of morphogenesis of
    atherosclerosis, although lime deposition begins
    already in the stage of atheromatosis and even
    liposclerosis.

28
CLINICOPATHOLOGIC TYPES
  • atherosclerosis of the aorta
  • atherosclerosis of the coronary arteries of the
    heart (cardiac form, cardiac ischemia)
  • atherosclerosis of the cerebral arteries (brain
    form of fibrovascular disease)
  • atherosclerosis of renal arteries (renal form)
  • atherosclerosis of the intestinal arteries
    (intestinal form)
  • atherosclerosis of arteries of lower extremities

29
WHAT HAPPENS
  • Slow narrowing of the feeding artery by an
    atherosclerotic plaque leads to chronic
    insufficiency of blood supply and ischemic
    changes - dystrophy and atrophy of the
    parenchyma, diffuse or fine-sclerotic sclerosis
    of the stroma.
  • Acute occlusion of the feeding artery, usually
    due to complicated lesions (plaque hemorrhage,
    thrombosis), leads to acute blood supply
    insufficiency and development of necrosis -
    infarction, gangrene.
  • In addition, in some cases, deep atheromatous
    ulcers can lead to the development of an
    aneurysm, i.e. the bulging of the artery wall in
    the lesion site followed by a rupture and a
    hemorrhage.

30
ATHEROSCLEROSIS OF THE AORTA
  • It is more sharply expressed in the abdominal
    part and is characterized by usually complicated
    lesions and calcification. In this regard, most
    often accompanied by thrombosis, thromboembolism
    and embolism atheromatous masses with the
    development of infarcts and gangrene (intestines,
    lower limbs).
  • Often an aortic aneurysm develops, which can be
    cylindrical, saccular or herniated. The wall of
    an aneurysm in some cases forms aorta (true
    aneurysm), in others - adjacent organs and
    hematoma (false aneurysm).

31
ATHEROSCLEROSIS OF THE CORONARY ARTERIES OF THE
HEART
  • lies at the heart of coronary heart disease, the
    morphological expression of which is focal
    ischemic dystrophy, myocardial infarction,
    large-focal (post-infarction) and diffuse
    small-focal cardiosclerosis.

32
ATHEROSCLEROSIS OF THE CEREBRAL ARTERIES
  • is the basis of cerebrovascular diseases, the
    most characteristic manifestations of which are
    ischemic and hemorrhagic cerebral infarction
    (stroke).
  • Prolonged ischemia of the cerebral cortex due to
    stenosing atherosclerosis leads to atrophy of the
    cerebral cortex, the development of
    atherosclerotic dementia.

33
ATHEROSCLEROSIS OF RENAL ARTERIES
  • or wedge-shaped areas of atrophy of the
    parenchyma with collapse and sclerosis of the
    stroma, or develop heart attacks followed by the
    formation of retracted scars.
  • As a result of ischemia of the kidney tissue with
    steno-scintillating atherosclerosis, symptomatic
    (renal) hypertension occurs.

34
ATHEROSCLEROSIS OF THE INTESTINAL ARTERIES
  • Atherosclerosis of the intestinal arteries,
    complicated by thrombosis, leads to gangrene of
    the gut.
  • Stenosing atherosclerosis of the mesenteric
    arteries can lead to the development of ischemic
    colitis, in which the splenic angle and the
    rectosigmoid parts of the colon are more often
    affected.

35
ATHEROSCLEROSIS OF ARTERIES OF LOWER EXTREMITIES
  • Atherosclerosis of arteries of the extremities
    femoral arteries are more often affected.
  • Stenosing atherosclerosis in the absence of
    collateral circulation leads to muscle atrophy
    and a characteristic symptom of intermittent
    claudication (pain that occurs in the legs when
    walking).
  • If atherosclerosis is complicated by thrombosis,
    then atherosclerotic gangrene develops.

36
HYPERTENSIVE DISEASE
37
DEFINITION
  • According to the WHO, it is a persistent increase
    in blood pressure systolic above 140 and
    diastolic - above 90 mm Hg.

38
THE DEGREE OF INCREASE IN BLOOD PRESSURE AND
CLINICAL COURSE
  • benign hypertension, characterized by a slow
    development and a moderate increase in blood
    pressure (the level of diastolic pressure does
    not exceed 110-120 mm Hg).
  • malignant hypertension, which is characterized by
    a significant increase in blood pressure (the
    level of diastolic pressure exceeds 110-120 mm
    Hg) and a rapidly progressive course leading to
    death in 1-2 years - occurs initially or as a
    complication of benign hypertension.

39
CLASSIFICATION
  • Primary essential - chronic disease, the main
    clinical manifestation of which is a prolonged
    and persistent increase in blood pressure
    (hypertension)
  • Secondary symptomatic

40
SECONDARY
  • Renal hypertension associated with kidney disease
    (nephrogenic hypertension) or renal vessels
    (renovascular hypertension).
  • Endocrine Hypertension
  • in case of excess of glucocorticoids - illness or
    syndrome of Itsenko-Cushing
  • with an excess of catecholamines -
    pheochromocytoma
  • with renin-producing kidney tumors.

41
SECONDARY
  • Neurogenic hypertension
  • increased intracranial pressure (trauma,
    opaquehol, abscess, hemorrhage)
  • b) with damage to the hypothalamus and brainstem
  • c) associated with psychogenic factors.
  • Other hypertension due to coarctation of the
    aorta and other anomalies of blood vessels,
    increase in volume circulate blood transfusion
    with excessive transfusion, polycythemia, etc.

42
RISK FACTORS
  • The greatest importance in the development of
    hypertension are given to the chronic
    psychological and emotional overstrain (frequent
    stresses, conflict situations, etc.) and
    excessive consumption of table salt.

43
PATHOLOGY
  • Malignant hypertension often occurs after a
    period of benign course, the average duration of
    which is about 10 years. Less often malignant
    course is observed from the very beginning.
  • More often malignant course is observed in men
    aged 35-50 years, sometimes up to 30 years.
  • The most characteristic sign of malignant
    hypertension is arteriolar necrosis.

44
PATHOLOGY
  • In benign hypertension, taking into account the
    duration of the development of the disease, three
    stages are distinguished
  • 1) preclinical
  • 2) common changes in the arteries
  • 3) changes in organs due to changes in arteries
    and violation of intraorganic circulation.
  • These stages are in good agreement with the
    stages of "benign" hypertension, proposed by WHO
    experts Stage I - mild course, II stage -
    moderate severity and stage III - hypertensive
    disease with severe course.

45
PRECLINICAL STAGE
  • Characterized by episodes of a temporary increase
    in blood pressure (transient hypertension).
  • At this stage, hypertrophy of the muscular layer
    and the elastic structures of the arterioles and
    their small branches, the morphological signs of
    arteriolar spasm or their deeper changes in cases
    of hypertensive crisis are found.
  • There is moderate compensatory hypertrophy of the
    left ventricle of the heart.

46
STAGE OF COMMON CHANGES IN THE ARTERIES
  • Characterizes the period of persistent increase
    in blood pressure, the degree of myocardial
    hypertrophy increases, the heart mass can reach
    900-1000 g, and the thickness of the wall of the
    left ventricle - 2-3 cm (cor bovinum - bovine
    heart).
  • Changes in the arteries of the elastic,
    muscular-elastic and muscular types are
    represented by elastofibrosis and
    atherosclerosis.
  • Plasmatic impregnation and its outcome -
    hyalinosis, or arteriolosclerosis - develop in
    connection with hypoxic injuries, which leads to
    vasospasms.
  • Similar changes appear in small arteries of the
    muscular type. Most often, arteriologinosis is
    noted in the kidneys, brain, pancreas, intestine,
    retina, capsule of the adrenal glands.

47
(No Transcript)
48
(No Transcript)
49
(No Transcript)
50
(No Transcript)
51
(No Transcript)
52
STAGE OF CHANGES IN ORGANS
  • Secondary changes in organs due to changes in
    arteries and violation of intraorganic
    circulation.
  • Secondary organ changes can develop slowly
    against the background of arterioles of o- and
    atherosclerotic occlusion of vessels, leading to
    atrophy of the parenchyma and sclerosis of the
    stroma.
  • In case of thrombosis, spasm, fibrinoid necrosis
    (more often during a crisis) acute changes occur
    - hemorrhages, infarcts.
  • Hyalinosis and fibrinoid necrosis with the
    development of microaneurysms are especially
    often found in the vessels of the brain, leading
    to intracerebral hemorrhages.

53
(No Transcript)
54
(No Transcript)
55
STAGE OF CHANGES IN ORGANS
  • Changes in the kidneys with chronic benign
    hypertension are caused by arteriolar hyalinosis
    (arteriolosclerosis), which is accompanied by
    collapse of capillary loops and glomerulus
    sclerosis (glomeruloskelethrosis), canal atrophy,
    compensatory hypertrophy of the remaining
    nephrons, which give the kidney surface a
    granular appearance.
  • The kidneys in this case decrease, become dense,
    the cortical substance becomes thinner. Such
    kidneys, which are the outcome of their sclerosis
    against the background of arteriolar hyalinosis
    (arti-rilosclerotic nephrosclerosis), are called
    primary-wrinkled.
  • Arteriolosclerotic nephrosclerosis can lead to
    the development of chronic renal failure.

56
(No Transcript)
57
CLINICOPATHOLOGIC TYPES
  • The cardiac form of hypertensive disease, like
    the cardiac form of atherosclerosis, is the
    essence of ischemic heart disease.
  • The cerebral form of hypertensive disease (like
    atherosclerosis of the brain vessels) underlies
    most cerebrovascular diseases.
  • The renal form of hypertension is characterized
    by both acute and chronic changes.

58
PROGNOSIS AND DEATH
  • The mortality rate of men over 40 years with
    blood pressure 150/100 mmHg. exceeds the average
    death rate by 125, women by 85.
  • Most people with benign form of hypertension die
    from heart failure, myocardial infarction,
    cerebral stroke (ischemic or hemorrhagic), or
    intercurrent diseases.
  • Approximately 5 of hypertensive patients develop
    malignant hypertension and they die from renal
    failure.

59
CARDIAC ISCHEMIA
60
CARDIAC ISCHEMIA
  • group of diseases caused by absolute or relative
    deficiency of coronary circulation. In the vast
    majority of cases, coronary heart disease (CHD)
    develops with atherosclerosis of the coronary
    arteries, so there is a synonym for the name -
    coronary disease.

61
RISK FACTORS
  • The most important risk factors of the first
    order are hyperlipidemia, tobacco smoking,
    arterial hypertension, decreased physical
    activity, obesity, nutritional factor
    (cholesterol diet), stress, decreased glucose
    tolerance, male sex, alcohol consumption.
  • Among the risk factors of the second order - the
    violation of the content of trace elements
    (zinc), increased water hardness, increased
    levels of calcium and fibrinogen in the blood,
    hyperuric acid,mia and others.

62
DIRECT REASONS
  • Immediate causes of ischemic myocardial damage in
    CHD include thrombosis of coronary arteries,
    bohemia thrombosis, prolonged spasm, functional
    myocardial overstrain under conditions of
    stenosing arteriosclerosis of coronary arteries
    and insufficient collateral circulation.

63
ISCHEMIA
  • Reversible ischemic lesions develop in the first
    20-30 minutes of ischemia and in the event of
    termination of the effect of the factor causing
    them, completely disappear. Morphological changes
    are found mainly in electron microscopy - the
    swelling of mitochondria, deformation of their
    cristae, relaxation of myofibrils.

64
MYOCARDIAL INFARCT
  • Irreversible ischemic damage to cardiomyocytes
    begins after ischemia lasting more than 20-30
    minutes.
  • After 18-24 h of ischemia, a necrosis zone is
    formed, visible micro- and macroscopically, i.e.
    a myocardial infarct is formed.

65
MYOCARDIAL INFARCT
  • Types of necrosis
  • coagulation - necrotic masses are removed by
    phagocytosis by macrophages
  • coagulation with subsequent myocytolysis -
    necrosis is located in the peripheral parts of
    the infarct and is caused by the action of
    ischemia and reperfusion
  • myocytolysis - colliquated necrosis necrotic
    masses are eliminated by lysis and phagocytosis

66
MYOCARDIAL INFARCTION
  • The form of acute ischemic heart disease,
    characterized by the development of ischemic
    necrosis of the myocardium. It develops 18 hours
    after the onset of ischemia, when the necrosis
    zone becomes visible micro- and macroscopically.
  • Macroscopically the infarct of the wrong form,
    white with a hemorrhagic aureole.
  • Microscopically determined zone of necrosis,
    surrounded by a zone of demarcation inflammation,
    separating the first from the preserved tissue of
    the myocardium. In the necrosis zone, coagulation
    necrosis in the center, coagulation myocytolysis
    and colliquated necrosis along the periphery are
    determined.
  • The zone of demarcation inflammation in the first
    days of the infarction is represented by the
    leukocyte shaft and full blood vessels with
    diapedesis, and from the 7th to the 10th day - a
    young connective tissue gradually replacing the
    necrosis and ripening zone. Scarring of the
    infarction occurs by the 6th week.
  • During the infarct, two stages are distinguished
    necrosis and scarring

67
CLASSIFICATION OF MYOCARDIAL INFARCTION
  1. By time of occurrence
  2. Primary (first emerged)
  3. Recurrent (developing within 6 weeks after the
    previous one)
  4. Repeated (developed more than 6 weeks after the
    previous one
  5. By localization
  6. The anterior wall of the left ventricle and the
    anterior parts of the interventricular septum
  7. Posterior wall of left ventricle
  8. The lateral wall of the left ventricleInterventric
    ular septum
  9. Extensive heart attack
  10. In the prevalence
  11. Subendocardial
  12. Intramural
  13. Subendocardial
  14. Transmural

68
COMPLICATIONS
  • cardiogenic shock, ventricular fibrillation,
    asystole, acute heart failure, myomation and
    heart rupture, acute aneurysm, parietal
    thrombosis with thromboembolic complications,
    pericarditis.
  • Mortality with myocardial infarction is 35 and
    develops most often in the early, preclinical
    period of the disease from lethal arrhythmias,
    cardiogenic shock and acute heart failure. In a
    later period - from thromboembolism and heart
    rupture, often in the area of acute aneurysm with
    a tamponade of the pericardial cavity.

69
(No Transcript)
70
(No Transcript)
71
(No Transcript)
72
(No Transcript)
73
(No Transcript)
74
(No Transcript)
75
(No Transcript)
76
LARGE-FOCAL (POST-INFARCTION) CARDIOSCLEROSIS
  • develops in the outcome of the transferred
    infarct and is represented by a fibrous tissue.
  • The stored myocardium undergoes regenerative
    hypertrophy. In the event that large-scale
    cardiosclerosis occurs after transmural
    myocardial infarction, a complication can occur-a
    chronic aneurysm of the heart.
  • Death comes from chronic heart failure or
    thromboembolic complications.

77
(No Transcript)
78
DIFFUSE SMALL-FOCAL CARDIOSCLEROSIS
  • As a form of chronic ischemic heart disease,
    diffuse small-focal cardiosclerosis develops as a
    result of relative coronary insufficiency with
    the development of small foci of ischemia.
  • It can be accompanied by atrophy and
    lipofuscinosis of cardiomyocytes.

79
(No Transcript)
80
RHEUMATIC DISEASES
81
DEFINITION
  • are a group of diseases characterized by
    affection of connective tissue due to a violation
    of the body's immune homeostasis (connective
    tissue disease with immune disorders).

82
WHO ARE IN GROUP
  • rheumatism, rheumatoid arthritis
  • systemic lupus erythematosus
  • Bekhterev's disease (Strumpell-Miarie disease)
  • systemic scleroderma
  • nodular periarteritis
  • dematomyositis

83
PATHOGENIC MECHANISM
  • The focus of chronic infection causes tension and
    perversion of the immune reaction of the body,
    resulting in autoimmunization, toxic immune
    complexes and immunocompetent cells that damage
    the micro-circulatory channel of certain organs
    or tissues.

84
COMMON SIGNS
  • presence of chronic focal infection
  • pronounced impairment of immunological
    homeostasis
  • generalized vasculitis
  • chronic undulating course
  • systemic progressive disorganization of the
    connective tissue

85
PRESENCE OF CHRONIC FOCAL INFECTION
  • It is known that B-hemolytic streptococcus group
    A is the cause of rheumatism.
  • Autoantogens antigens form the same immune
    complexes with autoantibodies, damaging various
    tissues and walls of blood vessels.

86
GENERALIZED VASCULITIS
  • The immediate-type hypersensitivity reaction is
    realized in the microcirculatory bed (capillary,
    venule, arteriola). As a result, destruction
    (fibrinoid necrosis), plasmorrhagia, thrombosis,
    endothelial proliferation and perithelium occur.
  • Morphologically, destructive-proliferative
    thrombovasculitis is identified, which can be
    endo-, meso-, peri-, and panvasculitis. The
    delayed-type hypersensitivity reaction is
    represented in this case by the proliferative
    component.

87
SYSTEMIC PROGRESSIVE DISORGANIZATION OF THE
CONNECTIVE TISSUE
  • is composed of 4 phases
  • - mucoid swelling
  • fibrinoid changes (manifestation of an immediate
    hypersensitivity reaction)
  • inflammatory cell reactions (expression of
    hypersensitivity reaction of immediate and
    delayed types)
  • - sclerosis

88
RHEUMATISM
89
DEFINITION
  • an infectious-allergic disease with a predominant
    lesion of the heart and vessels, undulating
    course, periods of exacerbation and fading.

90
ETHIOLOGY
  • The causative agent is (i-hemolytic group A
    streptococcus, which causes sensitization of the
    body (repeated angina).
  • Genic factors and age are of great importance in
    the onset of the disease.

91
CLINICOPATHOLOGIC TYPES
  • cardiovascular
  • polyarthritis
  • nodosa
  • cerebral

92
CARDIOVASCULAR TYPE
  • most frequent, occurs in both adults and
    children.
  • Endocarditis is the main manifestation of this
    form of rheumatism.
  • Localization distinguishes valvular, chordal,
    parietal endocarditis.
  • The most pronounced changes usually develop in
    the valves of the left atrioventricular (mitral)
    and aortic valves.
  • There are 4 types of rheumatic valvular
    endocarditis diffuse (or valvulitis), acute
    warty, fibroplastic, recurrently warty.

93
ENDOCARDITIS
  • Diffuse endocarditis - mucoid swelling, swelling
    of the connective tissue base of the valve, and
    the fullness of the capillaries. Endothelium is
    not affected, thrombotic overlap is absent.
  • Acute warty endocarditis - mucoid swelling,
    fibrinoid necrosis of the connective tissue and
    endothelium of the valves. The edges of the
    valves suffer particularly badly. As a result of
    the destruction of the endothelium, conditions
    are created for the formation of thrombi, which
    are located at the edge of the valve and are
    represented mainly by fibrin (white thrombus).
    Thrombotic overlays on the valves are called
    warts.

94
(No Transcript)
95
(No Transcript)
96
ENDOCARDITIS
  • Fibroplastic endocarditis develops as a
    consequence of the two previous forms of
    endocarditis and is characterized by a
    predominance of sclerosis and scarring.
  • Recurrent-warty endocarditis - disorganization of
    connective tissue in sclerotized valves -
    endothelial necrosis and the formation of warts
    on valves (thrombotic overlap of various sizes).
    In the outcome - sclerosis, hyalinosis of the
    valves.

97
(No Transcript)
98
(No Transcript)
99
MYOCARDITIS
  • one of the frequent manifestations of rheumatism.
  • There are 3 forms of myocarditis nodular
    (granulomatous), diffuse interstitial
    (interstitial) exudative, focal interstitial
    (interstitial) exudative.
  • Nodular myocarditis - granulomas in the
    perivascular connective tissue of various parts
    of the heart. Granulomas might be in various
    phases of development "blossoming," "fading,"
    "scarring." In myocytes, protein or fatty
    degeneration is noted to varying degrees. Nodular
    myocarditis is terminated by diffuse small-focal
    cardiosclerosis.

100
(No Transcript)
101
(No Transcript)
102
MYOCARDITIS
  • Diffuse interstitial exudative myocarditis
    (mainly in children) - infiltration of stroma
    with lymphocytes, histiocytes, neutrophilic and
    eosinophilic leukocytes. Vessels full-blooded,
    pronounced edema of the stroma. The myocardium
    loses its tone, becomes flabby, the heart
    cavities expand, so the clinical manifestation of
    this myocarditis is always severe cardiovascular
    failure. In the outcome in the myocardium
    develops diffuse cardiosclerosis.
  • Focal interstitial exudative myocarditis has the
    same morphological manifestations as diffuse,
    only the process is focal. Clinically, it usually
    takes place latently. At the end there is focal
    cardiosclerosis.

103
(No Transcript)
104
PERICARDITIS
  • Pericarditis in rheumatism is serous, fibrinous
    and serous-fibrinous.
  • Pericarditis results in the formation of
    adhesions in the pericardial cavity.
  • Sometimes complete obliteration of the
    pericardial cavity and even calcification of
    fibrinous superimposed (palpable heart) are
    possible.

105
(No Transcript)
106
VASCULITIS
  • Rheumatic vasculitis, especially the
    microcirculatory bed, is very characteristic.
  • Arteries and arterioles develop fibrinoid
    necrosis, thrombosis, proliferation of
    endothelial and adventitial cells.
  • The permeability of the walls of the vessels is
    increased.
  • Diapedemic hemorrhages and sometimes larger
    hemorrhages are possible.
  • Arteriosclerosis arises in the outcome of
    rheumatic vasculitis.

107
POLYARTHRITIS TYPE
  • Occurs in 10-15 of patients.
  • Mostly small and large joints are affected -
    serous-fibrinous inflammation.
  • The synovial membrane is full-blooded, vasculitis
    is expressed, the synoviocytes proliferate, the
    connective tissue undergoes mucoid swelling, and
    exudate (usually serous) forms in the joint
    cavity.
  • Articular cartilage is not involved in the
    process, therefore, with rheumatism, joint
    deformities are usually not observed.

108
NODOSA TYPE
  • Characterized by the phenomena of disorganization
    of connective tissue in the periarticular region
    and along the tendons - large foci of fibrinoid
    necrosis are found, surrounded by a cellular
    reaction (lymphocytes, macrophages, histiocytes)
    - nodosa erythema develops.

109
CEREBRAL TYPE
  • It is caused by the development of rheumatic
    vasculitis.
  • If occurs in children, called small chorea.
  • In addition to rheumatic vasculitis, especially
    at the level of microcirculation, there are
    dystrophic and necrobiotic changes in the brain
    tissue, small hemorrhages.
  • The defeat of other organs and tissues is poorly
    represented, although it is always detected with
    a purposeful examination.

110
COMPLICATIONS
  • most often associated with the development of
    thromboembolic syndrome caused by warty
    endocarditis.
  • With heart disease, cardiovascular failure
    develops, which is associated with myocardial
    decompensation.
  • Sometimes various complications can cause
    adhesion in the cavities of the pericardium,
    pleura, abdominal cavity.

111
PRACTICAL PART
112
GROSS SPECIMENS
113
? 143. ATHEROSCLEROSIS OF THE AORTA
  • From the intima side multiple foci of
    atherosclerotic lesions of the aorta are visible
    fat spots and bands, uncomplicated fibrous
    plaques, ulcerated plaques and plaques with
    thrombotic overlays and calcification.

114
? 148A. RUPTURE OF THE HEART WALL (RUPTURA
CORDIS) IN THE ACUTE STAGE OF MYOCARDIAL
INFARCTION
  • In the lateral wall of the left ventricle of the
    heart there is a through defect of a slit shape
    up to 3 cm long.

115
? 149. CHRONIC ANEURYSM OF THE HEART
  • The anterior and lateral walls of the left
    ventricle of the heart are thinned, forming
    protrusion (aneurysm). Wall of an aneurysm of
    dense-elastic consistency, whitish-gray color
    (due to scar tissue). In the aneurysmal cavity,
    parietal thrombi are visible.

116
? 150. SCARRING OF THE KIDNEY DURING
ATHEROSCLEROSIS (ATHEROSCLEROTIC SHRIVELED KIDNEY)
  • The size of the organ is usually unchanged the
    kidney tissue is densified. Its surface with
    numerous, intertwined narrow deep cicatricial
    depressions.

117
? 151 (91). HYPERTROPHY OF THE MYOCARDIUM OF THE
LEFT VENTRICLE WITH ARTERIAL HYPERTENSION
  • The heart is enlarged by the left ventricle. The
    thickness of the myocardium of the left ventricle
    at its base is 1.5 cm (or more). The thickness of
    the myocardium of the right ventricle within the
    norm (less than 0.5 cm).

118
? 152. PRIMARILY WRINKLED KIDNEY
(CICATRICIAL-WRINKLED KIDNEY WITH PRIMARY
ARTERIAL HYPERTENSION)
  • The kidneys are reduced, compacted. Fibrous
    capsules are easily removed, exposing the
    fine-grained surface.

119
? 153. ACUTE WARTY ENDOCARDITIS OF THE MITRAL
VALVE IN RHEUMATISM
  • Valve leaflets slightly thickened, soft,
    translucency reduced. On the surface of the
    leaflets at the closing edge there are small
    thrombotic overlays in the form of towering knots
    ("warts").

120
? 154. RECURRENT-WARTY ENDOCARDITIS OF THE MITRAL
VALVE IN RHEUMATISM
  • Valves are thickened, compacted, whitish-gray,
    opaque, fused together. On the surface of the
    deformed valve flaps, fresh thrombotic overlays
    are located.

121
? 156. HEART WITH RHEUMATIC MITRAL STENOSIS
  • Valves are thickened, compacted, whitish-gray,
    opaque, fused together. The left atrioventricular
    aperture is narrowed (mitral stenosis). On the
    surface of the valves, a fresh thrombotic overlap
    is located along the closing edge, giving the
    mitral opening the appearance of a "fish mouth".

122
? 157. HEART WITH DECOMPENSATED RHEUMATIC
MALFORMATION
  • The heart is enlarged, its cavities are dilated,
    the walls are thinned (in comparison with the
    compensated state). Myocardium looks clayey
    (flabby, yellowish-gray).

123
SLIDES
124
? 32. ATHEROSCLEROTIC PLAQUE OF THE AORTA IN THE
STAGE OF ATHEROMATOSIS
  • Staining with Sudan III.
  • A cut of the aortic wall through the center of
    the atherosclerotic plaque. The central sections
    of the plaque occupy a rich fat detritus, colored
    by Sudan III in orange. The plaque cover is
    preserved. Nearby the wall of the normal aorta is
    visible.

125
? 222A. MYOCARDIAL INFARCTION, NECROTIC (ACUTE)
STAGE
  • Staining with hematoxylin and eosin.
  • The site of myocardial necrosis is formed by
    hypereosinophilic detritus. In some preparations,
    contours of the destroyed muscle fibers are
    visible (heterogeneous phase of necrosis),
    however, the cell nuclei in these areas are not
    detected. In the preserved tissue near the
    infarct, the microvessels are surrounded by cells
    of the inflammatory infiltrate, primarily
    neutrophilic granulocytes and macrophages
    (demarcation inflammation).

126
? 222?, 222?. MYOCARDIAL INFARCTION, STAGE OF
ORGANIZATION
  • Staining with hematoxylin and eosin.
  • The area of ??necrosis is replaced by a fibrous
    connective tissue granulation can be seen in the
    preparation ? 222c and coarse-fiber (scar) in the
    preparation ? 222?. Cardiomyocytes, located
    around the cicatrix, are thickened their nuclei
    are enlarged, irregularly shaped, hyperchromic
    (signs of hypertrophy).

127
? 148. RECURRENT-WARTY ENDOCARDITIS
  • Staining with hematoxylin and eosin.
  • Tissues show vessels (normally they are absent),
    severe fibrosis, fibrinoid necrosis foci
    (amorphous acellular eosinophilic masses), focal
    lymphohystiocytic infiltrate. On the surface of
    the valve with endothelium devotion, there are
    thrombotic overlays in the form of eosinophilic
    amorphous masses. Part of the thrombotic overlap
    is partially or completely replaced by fibrous
    tissue.

128
? 149. GRANULOMATOUS RHEUMATIC MYOCARDITIS
  • Staining with hematoxylin and eosin.
  • In the myocardium between the bundles of muscle
    fibers there are numerous fading rheumatic
    granulomas Áshoff-Talalayeva.

129
? 150. CARDIOSCLEROSIS IN THE OUTCOME OF
RHEUMATIC MYOCARDITIS
  • Staining with van Gieson.
  • In the stroma of the myocardium, mainly around
    small vessels, interlayers of dense fibrous
    tissue are found, the collagen fibers of which
    are colored red with acid fuchsin.
Write a Comment
User Comments (0)
About PowerShow.com